JP2020518604A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020518604A5 JP2020518604A5 JP2019560115A JP2019560115A JP2020518604A5 JP 2020518604 A5 JP2020518604 A5 JP 2020518604A5 JP 2019560115 A JP2019560115 A JP 2019560115A JP 2019560115 A JP2019560115 A JP 2019560115A JP 2020518604 A5 JP2020518604 A5 JP 2020518604A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- immunoglobulin
- patient
- ige
- antagonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762501806P | 2017-05-05 | 2017-05-05 | |
| US62/501,806 | 2017-05-05 | ||
| PCT/IB2018/053106 WO2018203289A1 (en) | 2017-05-05 | 2018-05-04 | Methods of selectively treating asthma using il-17 antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020518604A JP2020518604A (ja) | 2020-06-25 |
| JP2020518604A5 true JP2020518604A5 (https=) | 2020-09-24 |
Family
ID=62245372
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019560115A Pending JP2020518604A (ja) | 2017-05-05 | 2018-05-04 | Ｉｌ−１７アンタゴニストを使用して喘息を選択的に治療する方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10676522B2 (https=) |
| EP (1) | EP3619536A1 (https=) |
| JP (1) | JP2020518604A (https=) |
| KR (1) | KR20190142398A (https=) |
| CN (1) | CN110582702A (https=) |
| AU (1) | AU2018263159A1 (https=) |
| BR (1) | BR112019023141A2 (https=) |
| CA (1) | CA3062179A1 (https=) |
| CL (1) | CL2019003161A1 (https=) |
| MX (1) | MX2019013160A (https=) |
| RU (1) | RU2019139387A (https=) |
| TW (1) | TW201842933A (https=) |
| WO (1) | WO2018203289A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3689907A1 (en) * | 2019-01-31 | 2020-08-05 | Numab Therapeutics AG | Antibodies targeting il-17a and methods of use thereof |
| CN115362173A (zh) * | 2020-04-17 | 2022-11-18 | 伊莱利利公司 | 呼吸系统疾病的治疗 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0308324D0 (en) | 2003-04-10 | 2003-05-14 | Piezoptic Ltd | A chemical sensing device |
| CN1898564A (zh) * | 2003-12-24 | 2007-01-17 | 惠氏公司 | 治疗哮喘的方法 |
| GB0417487D0 (en) | 2004-08-05 | 2004-09-08 | Novartis Ag | Organic compound |
| GB0425569D0 (en) | 2004-11-19 | 2004-12-22 | Celltech R&D Ltd | Biological products |
| EP1963368B3 (en) | 2005-12-13 | 2020-06-10 | Eli Lilly And Company | Anti-il-17 antibodies |
| GB0612928D0 (en) | 2006-06-29 | 2006-08-09 | Ucb Sa | Biological products |
| US7767206B2 (en) | 2006-10-02 | 2010-08-03 | Amgen Inc. | Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto |
| BRPI0906261A2 (pt) | 2008-03-31 | 2015-07-07 | Genentech Inc | "métodos de diagnóstico de um subtipo de asma em uma amostra de paciente, usos de um agente terapêutico e kits de diagnóstico de um subtipo de asma em uma amostra de paciente" |
| NZ591484A (en) | 2008-09-29 | 2012-09-28 | Roche Glycart Ag | Antibodies against human il 17 and uses thereof |
| LT2953969T (lt) | 2013-02-08 | 2019-12-10 | Novartis Ag | Anti-il-17a antikūnai ir jų panaudojimas autoimuninių ir uždegiminių ligų gydymui |
| AR098155A1 (es) * | 2013-10-23 | 2016-05-04 | Genentech Inc | Métodos para diagnosticar y tratar trastornos eosinofílicos |
| WO2015191783A2 (en) * | 2014-06-10 | 2015-12-17 | Abbvie Inc. | Biomarkers for inflammatory disease and methods of using same |
| CN115957326A (zh) * | 2014-09-10 | 2023-04-14 | 诺华股份有限公司 | 使用il-17拮抗剂抑制银屑病关节炎患者的结构损伤进展 |
| GB201508832D0 (en) | 2015-05-22 | 2015-07-01 | Novartis Ag | A method for detecting an analyte |
-
2018
- 2018-05-03 TW TW107114983A patent/TW201842933A/zh unknown
- 2018-05-03 US US15/969,952 patent/US10676522B2/en active Active
- 2018-05-04 CN CN201880029544.7A patent/CN110582702A/zh active Pending
- 2018-05-04 AU AU2018263159A patent/AU2018263159A1/en not_active Abandoned
- 2018-05-04 JP JP2019560115A patent/JP2020518604A/ja active Pending
- 2018-05-04 KR KR1020197035578A patent/KR20190142398A/ko not_active Abandoned
- 2018-05-04 RU RU2019139387A patent/RU2019139387A/ru not_active Application Discontinuation
- 2018-05-04 MX MX2019013160A patent/MX2019013160A/es unknown
- 2018-05-04 WO PCT/IB2018/053106 patent/WO2018203289A1/en not_active Ceased
- 2018-05-04 EP EP18727435.2A patent/EP3619536A1/en not_active Withdrawn
- 2018-05-04 CA CA3062179A patent/CA3062179A1/en not_active Abandoned
- 2018-05-04 BR BR112019023141-2A patent/BR112019023141A2/pt not_active Application Discontinuation
-
2019
- 2019-11-04 CL CL2019003161A patent/CL2019003161A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12044681B2 (en) | Protein signatures for distinguishing between bacterial and viral infections | |
| Laing et al. | A dynamic COVID-19 immune signature includes associations with poor prognosis | |
| US20240369552A1 (en) | Early diagnosis of infections | |
| EP3475702B3 (en) | Measuring trail by lateral flow immunoassay | |
| Yu et al. | mRNA vaccine-induced antibodies more effective than natural immunity in neutralizing SARS-CoV-2 and its high affinity variants | |
| EP4033248B1 (en) | System and method for analysis of mx1 and crp in blood | |
| CN105980856A (zh) | 用于早期确定对疾病的危象反应或威胁生命反应和/或治疗反应的生物标志物 | |
| JP2022160422A (ja) | エキソソームの亜集団の定量および神経変性障害の診断 | |
| Tawalbeh et al. | Serum protein biomarkers for juvenile dermatomyositis: a pilot study | |
| Jalali et al. | Aptamer based diagnosis of crimean-congo hemorrhagic fever from clinical specimens | |
| CN113791212B (zh) | 新型冠状病毒中和抗体磁珠荧光检测试剂盒及其检测方法 | |
| CN112415195A (zh) | 检测新型冠状病毒双靶点的试剂盒及其应用 | |
| JP2020518604A5 (https=) | ||
| JP2024534348A5 (https=) | ||
| JP2005510696A5 (https=) | ||
| JP2007502837A5 (https=) | ||
| JP2019526231A (ja) | 二本鎖核酸信号プローブおよびこれを用いた標的分子の検出方法 | |
| Brasier et al. | Discovery proteomics and nonparametric modeling pipeline in the development of a candidate biomarker panel for dengue hemorrhagic fever | |
| CN103243101A (zh) | 一组特异性识别金黄色葡萄球菌肠毒素c1的核酸适配体 | |
| WO2023034933A1 (en) | Methods and systems for assessing adaptive immunity to coronavirus | |
| RU2019139387A (ru) | Способы селективного лечения астмы с использованием антагонистов il-17 | |
| JP2019032317A5 (https=) | ||
| Grace et al. | Latex agglutination test for rapid on-site serodiagnosis of Japanese encephalitis in pigs using recombinant NS1 antigen | |
| CN103045600B (zh) | 结核患者血清IgG抗体适配子及其制备方法 | |
| US20200284799A1 (en) | Rapid test for cellular fibronectin |